Journals / MN Oftalmoloji / 2013 / Cilt: 20 - Sayı: 1

BCG scar diameters in vernal conjunctivitis and healthy children

Vernal konjunktivit ve sağlıklı çocuklarda BCG skar çapları

Pages
60–63
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In conclusion, we could not find any differences in the size of BCG scars and BCG scar count between two groups.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In the last decades the prevalence of allergic diseases has risen in developed countries.
📊
Key Findings & Data:The reason for this increases are unclear.
💡
Conclusion & Impact:Conclusion: In conclusion, we could not find any differences in the size of BCG scars and BCG scar count between two groups.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: In the last decades the prevalence of allergic diseases has risen in developed countries. The reason for this increases are unclear. Mycobacterial products may have protective effects for allergic diseases. But the relationship between mycobacteria and allergic diseases is still controversial. We aimed to compare the BCG scar size in vernal conjunctivitis and healthy children in this study. Material and Method: Seventeen children who were diagnosed as vernal conjunctivitis and seventeen healthy children were enrolled in this study. Ophthalmological examination of all children was done. The size of BCG scar and their counts were evaluated on their left arms in two groups. Personal history of atopy was recorded in each group. Results: Distribution of age and gender was similar in two groups. BCG scar count (p=0.300) and average horizontal-vertical scar size (p=0.440, p=0.624) was not significantly different between two groups. But personal history of atopy was significantly higher in study group than the control group (p=0.044). Conclusion: In conclusion, we could not find any differences in the size of BCG scars and BCG scar count between two groups. Our study suggests that vernal conjunctivitis has a more complex pathophysiology.

Özet

artmaktadır. Bu artışın nedeni kesin olarak belli değildir. Mikobakteryel ürünlerin allerjik hastalıklardan koruyucu etkileri olabilir ancak mikobakteriler ve allerjik hastalıklar arasındaki ilişki halen tartışmalıdır. Bu çalışmada vernal konjunktivit ve sağlıklı çocuklardaki BCG skar çaplarının karşılaştırması amaçlanmıştır. Gereç ve Yöntem: Vernal konjunktivit tanısı konan on yedi hasta ile on yedi sağlıklı çocuk çalışmaya dahil edildi. Tüm çocuklara tam bir oftalmolojik muayene yapıldı. Çalışma ve kontrol grubundaki çocukların sol omuzlarında yer alan BCG iz çapı ve sayısı değerlendirildi. Kişisel atopi öyküsü sorgulanarak, her iki grupta kaydedildi. Bulgular: Yaş ve cinsiyet dağılımı her iki grupta benzerdi. BCG iz sayısı (p=0,300) ve ortalama yatay-dikey iz çapları (p=0,440, p=0,624) karşılaştırıldığında iki grup arasındaki farkın istatistiksel olarak anlamlı olmadığı saptandı. Fakat bireysel atopi öyküsü çalışma grubunda yer alan çocuklarda kontrol grubunda yer alan çocuklara göre anlamlı olarak yüksekti (p=0,044). Sonuç: İki grup arasında BCG iz çapları ve BCG iz sayıları yönünden fark bulamadık. Bu durum vernal konjUnktivit patofizyolojisinin daha karmaşık olduğunu gösterebilir.

🔖

Cite This Article

DİNÇ, E., GÖKSEL, İ., ADIGÜZEL, U., YILDIRIM, Ö., AYDIN, B., TEMEL, G. O. (2013). BCG scar diameters in vernal conjunctivitis and healthy children. MN Oftalmoloji, Cilt: 20 - Sayı: 1, 60–63. https://ajindex.com/articles/295616

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Woolcock AJ, Peat JK. Evidence for the increase in asthma worldwide. In: Ciba Foundation Editor. The Rising Trends in Asthma. John Wiley & Sons, Chiester 1997;122-39
  2. Von Hertzen LC. The hygiene hypothesis in the development of atophy and asthma stil a matter of controversy? Q J Med 1998;91:767-71
  3. Strachan DP. Hay fever, hygiene and household size. BMJ 1989;299:1259-60
  4. Walker C, Sawicka E, Rodi G. Immunotheraphy with mycobacteria. Curr Opin Allergy Clin Immunol 2003;3:481-92
  5. Dursun AB, Mungan D. Mikobakteriler ve alerjik hastalıklar. Astım Alerji İmmünoloji 2004;2:89-94
  6. Obihara CC, Bollen CW, Beyers N, et al. Mycobacterial infection and atopy in childhood: A systematic review. Pediatr Allergy Immunol 2007;18:551-9
  7. Floyd S, Ponnighans JM, Bliss L, et al. BCG scars in northern Malawi: sensitivity and repeatability of scar reading, and factors affecting scar size. Int J Tuber Lung Dis 2000;4:1133-42
  8. Tomaç N. Alerjik konjunktivitler. T Klin J Med Sci 2004;24:396- 410
  9. Uchio E, Ono SY, Ikezawa Z, et al. Tear levels of interferongamma, interleukin (IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin Exp Allergy 2000;30:103-9
  10. Metz DP, Hingorani M, Calder VL, et al. T cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol 1997; 100:817-24
  11. Stern ME, Siemasko K, Gao J, et al. Role of interferongamma in a mouse model of allergic conjunctivitis. Invest Ophthalmol Vis Sci 2005;46:3239-46
  12. Sari A, Dinc E, Yilmaz BC, et al. Inducing ocular allergy with β-lactoglobulin: a new experimental model. Opthalmic Res 2010;44:119-24
  13. Bibakis I, Zekveld C, Dimitroulis I, et al. Childhood atopy and allergic disease and skin test responses to environmental mycobacteria in rural Crete: a cross-sectional survey. Clin Exp Allergy 2005;35:624-9
  14. Steenhuis TJ, van Aalderen WM, Bloksma N, et al. Bacille- Calmette-Guerin vaccination and the development of allergic disease in children: a randomized, prospective, single-blind study. Clin Exp Allergy 2008;38:79-85.